• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    FibroBiologics, Inc. - Common Stock (NQ:FBLG)

    0.4192 +0.0435 (+11.58%)
    Streaming Delayed Price Updated: 4:00 PM EST, Mar 5, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,323,884
    Open 0.3900
    Bid (Size) 0.4200 (200)
    Ask (Size) 0.4293 (300)
    Prev. Close 0.3757
    Today's Range 0.3800 - 0.4390
    52wk Range 0.2201 - 1.530
    Shares Outstanding 38,262,586
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    FibroBiologics Completes Site Onboarding for Phase 1/2 Clinical Trial for CYWC628 for the Treatment of Refractory Diabetic Foot Ulcers
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics, Inc. Announces Issuance of U.S. Patent Covering Fibroblast Cell Therapy for the Treatment of Osteoporosis
    From FibroBiologics, Inc.
    Via GlobeNewswire

    Performance

    YTD
    +74.7%
    +74.7%
    1 Month
    +51.2%
    +51.2%
    3 Month
    +61.2%
    +61.2%
    6 Month
    -29.4%
    -29.4%
    1 Year
    -64.2%
    -64.2%

    More News

    Read More
    News headline image
    FibroBiologics to Present at the BIO Investment & Growth Summit
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Reports Full Year 2025 Financial Results and Provides Corporate Update
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Granted Extension by Nasdaq to Regain Compliance
    From FibroBiologics, Inc.
    Via GlobeNewswire
    Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
    Via Chartmill
    News headline image
    FibroBiologics’ Chairman & CEO Pete O’Heeron Selected to Present at A4LI’s H-SPAN Summit at Georgetown University
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Announces Issuance of Canadian Patent Covering Novel Fibroblast-Based Treatment for Cachexia
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics to Present at the DealFlow Discovery Conference
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics CEO Issues Letter to Shareholders
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics to Present at 9th Annual BFC Global Healthcare Business Development and Investment Conference
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    Monday's session: top gainers and losers ↗
    Via Chartmill
    News headline image
    Which stocks are gapping on Monday? ↗
    Via Chartmill
    News headline image
    Monday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    FibroBiologics Announces $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Announces Payoff of Outstanding Debt
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From FibroBiologics, Inc.
    Via GlobeNewswire
    News headline image
    Which stocks are experiencing notable movement on Monday? ↗
    Via Chartmill
    News headline image
    Top movers in Monday's session ↗
    Via Chartmill
    News headline image
    The market is filled with gapping stocks in Monday's session. ↗
    Via Chartmill
    News headline image
    FibroBiologics Announces $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    From FibroBiologics, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is FibroBiologics, Inc. - Common Stock publicly traded?
    Yes, FibroBiologics, Inc. - Common Stock is publicly traded.
    What exchange does FibroBiologics, Inc. - Common Stock trade on?
    FibroBiologics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for FibroBiologics, Inc. - Common Stock?
    The ticker symbol for FibroBiologics, Inc. - Common Stock is FBLG on the Nasdaq Stock Market
    What is the current price of FibroBiologics, Inc. - Common Stock?
    The current price of FibroBiologics, Inc. - Common Stock is 0.4192
    When was FibroBiologics, Inc. - Common Stock last traded?
    The last trade of FibroBiologics, Inc. - Common Stock was at 03/05/26 04:00 PM ET
    What is the market capitalization of FibroBiologics, Inc. - Common Stock?
    The market capitalization of FibroBiologics, Inc. - Common Stock is 16.04M
    How many shares of FibroBiologics, Inc. - Common Stock are outstanding?
    FibroBiologics, Inc. - Common Stock has 16M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.